Panbela Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for PBLA

Based on 2 analysts offering 12 month price targets for Panbela Therapeutics Inc.
Min Forecast
Avg Forecast
Max Forecast

Should I buy or sell PBLA stock?

Based on 2 analysts offering ratings for Panbela Therapeutics Inc.
Strong Buy
Strong Buy
2 analysts 100%
0 analysts 0%
0 analysts 0%
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their PBLA stock forecasts and price targets.

PBLA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Maxim Group
Bottom 4%
Strong BuyUpgrades$1.50+199.40%2023-03-20
Roth Capital
Bottom 11%
Strong BuyReinstates$10.00+1,896.01%2023-01-31

1 of 1

PBLA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
PBLA$0.50$5.75+1,047.70%Strong Buy
SONN$0.36$6.70+1,766.30%Strong Buy

Panbela Therapeutics Stock Forecast FAQ

Is Panbela Therapeutics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: PBLA) stock is to Strong Buy PBLA stock.

Out of 2 analysts, 2 (100%) are recommending PBLA as a Strong Buy, 0 (0%) are recommending PBLA as a Buy, 0 (0%) are recommending PBLA as a Hold, 0 (0%) are recommending PBLA as a Sell, and 0 (0%) are recommending PBLA as a Strong Sell.

If you're new to stock investing, here's how to buy Panbela Therapeutics stock.

What is PBLA's Price Target?

According to 2 Wall Street analysts that have issued a 1 year PBLA price target, the average PBLA price target is $5.75, with the highest PBLA stock price forecast at $10.00 and the lowest PBLA stock price forecast at $1.50.

On average, Wall Street analysts predict that Panbela Therapeutics's share price could reach $5.75 by Mar 20, 2024. The average Panbela Therapeutics stock price prediction forecasts a potential upside of 1,047.7% from the current PBLA share price of $0.50.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.